Time To Buy? The ZOM stock was last … Target Odds. The consensus price target for the stock as assigned by Wall Street analysts is $0.3, meaning bulls need a downside of -70.59% from its current market value. Zomedica Corp. (NYSE:ZOM) trade information. Announces Closing of $173.5 Million Bought Deal GlobeNewswire Inc. - 2/11/2021 12:18:17 PM: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) … Upside. The consensus price target as assigned by Wall Street analysts is $0.3, which translates to bears needing to reduce their stock price by -69.39% from its current value. Zomedica (NYSE:ZOM) is a stock that is absolutely on fire right now. Investors can use this forecasting interface to forecast Zomedica Pharmaceuticals historical stock prices and determine the direction of Zomedica Pharmaceuticals Corp's future trends based on various well-known forecasting models. Time To Buy? Stock’s current price level is -51.61% above from estimated low price target while it is -51.61% below the estimated high; and even if the ZOM’s share succeeded to reach the median price of $1.2, then the outlook of -51.61% could … … On average, they expect Zomedica's stock price to reach $0.30 in the next year. As such, ZOM has been trading -45.7% off suggested target high and -45.7% from its likely low. Zomedica Pharmaceuticals Stock Price Prediction Analysis Have you ever been surprised when a … Find the latest Zomedica Corp. (ZOM) stock quote, history, news and other vital information to help you with your stock trading and investing. Feb 23, 2021 6:01AM EST. Considering analysts have assigned the stock a price target range of $0.3-$0.3 as the low and high respectively, we find the trailing 12-month average consensus price target to be $0.3. The extremes of the forecast give a target low and a target high price of $0.3 and $0.3 respectively. Stocks; IPOs; News; Actions; Blog; Stocks; IPOs; News; Actions; Blog; Search Home » Stocks » ZOM. As a result, ZOM is trading at a discount of -70% off the target high and -70% off the low. Stocks. Analyst projections state that ZOM is forecast to be at a low of $0.3 and a high of $0.3. Get the latest Zomedica (ZOM) stock price quote with real-time news, financials, charts and other important investing information. 21st of February 2021. Massive News! Get the latest Zomedica (ZOM) stock price quote with real-time news, financials, charts and other important investing information. Zomedica Pharmaceuticals Stock Forecast is based on your current time horizon. Zomedica Corp.(NYSE:ZOM): Pet care stocks have been on a solid run of late as homebound lifestyles have caused more Americans to adopt pets. In order for the stock price to hit the forecast high, the stock would need to surge -69.39% from its current level, while the stock would … The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Zomedica Corp. So what. … Wall Street analysts have assigned a consensus price target of $1.2 to the stock, which implies targetted prices is already lagging behind -54.89% to its current value. Below Odds . The stock ended 2020 priced at $0.23 but has since steadily climbed to its closing price on Friday of $2.57 which represents gains of over 1,000% in 2021 alone. Analysts on Wall Street suggest a consensus price target of $1.2, implying a decline of -45.7% to the stock’s current value. Price Target! The average price target for the stock over the next 12 months is $0.3, with the estimates having a low of $0.3 and a high of $0.3. Huge stock price increase in a very short time…3 months (Nov 12, 2020 $0.08 to $2.57 Feb 12, 2021)….Future revenues may be baked into the price 2. Zomedica Corp. analyst ratings, historical stock prices, earnings estimates & actuals. Considering analysts have assigned the stock a price target range of $1.2-$1.2 as the low and high respectively, we find the trailing 12-month average consensus price target to be $1.2. However, solely looking at the historical price movement is usually misleading. Reaching $3? The average price target for the stock over the next 12 months is $1.2, with the estimates having a low of $1.2 and a high of $1.2. The extremes give us $1.2 and $1.2 for target low and target high price respectively. Skip to content. Above Odds . Contributor . Zomedica Stock Forecast, ZOM stock price prediction. Price target in 14 days: 3.643 USD. Analyst Opinion on Zomedica (NYSEAMERICAN:ZOM) 1 Wall Street analysts have issued ratings and price targets for Zomedica in the last 12 months. As of 12:25 p.m. EST, the veterinary health company's stock price was up more than 24%. Keith Speights The Motley Fool Published. The earnings rating for Zomedica Pharmaceuticals Corp. stock is Neutral (calculated from actual period earnings estimates revision … While the price target on the stock is only $0.30 per share, the target was set prior to the announcement of the coming launch of TRUFORMA. After-hype Price. The consensus price target of analysts on Wall Street is $0.3, which implies a decline of -70% to the stock’s current value. An analysis of the company’s … Guru’s Opinion on Zomedica Corp. [ZOM]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZOM shares is $1.20 per share. Their average twelve-month price target is $0.30, predicting that the stock has a possible downside of 86.84%. By Zomedica’s own stock sales, it sold off two-thirds of the equity of the company for just $50 million. These price ends are -72.97% and -72.97% off the today’s price level respectively, although investors could be excited at the prospect of a -72.97% if the ZOM share price touches on the median price of $0.3. Analysts have been projecting $1.2 as a low price target for the stock while placing it at a high target of $1.2. Zomedica Corp. (AMEX: ZOM) is 888.73% higher on its value in year-to-date trading and has touched a low of $0.06 and a high of $2.91 in the current 52-week trading range. Their forecasts range from $0.30 to $0.30. At the time, Zomedica’s stock price was around 20 cents. Indeed, ZOM stock has provided investors with a year-to-date return of 880% at the time of publication. With a clear breakout, and with its new TRUFORMA product, almost ready for commercialization, ZOM is finally showing some strength that I think will persist for Q3 and Q4 of 2021, taking the stock to way higher prices. 0.15 . Zomedica (NYSEMKT: ZOM) is sizzling hot right now. Zomedica Pharmaceuticals Corp.’s next earnings report date is 24th Feb 2021. Get Trade Advice. The average equity rating for ZOM stock is currently 2.00, trading closer to a bullish pattern in the stock market. Huge Potential, Price Target! This suggests that the stock has a possible downside of 86.8%. Northern’s shares are priced at $10.99 and they have an average price target of $14.75, indicating that the stock has a 34% one-year upside potential. Analysis and calculation of next after-hype price of Zomedica Pharmaceuticals is based on 3 months time horizon. Zomedica Stock Price Prediction. Why This Pet Stock Is a Better Bet Than Zomedica. The penny stock has not seen price levels above $1.35 since 2018 For yet another consecutive day, shares of Zomedica Corp. rocketed higher. Zomedica Corp. (ZOM) projections and forecasts. In this video, I talk about a Zomedica stock price target and update. Zomedica (zom) Stock! The immediate target is the 15 cents level, and then the 20 cents level, watch these. Against this backdrop, we think shares of veterinary diagnostic company Zomedica Corp. (ZOM) are well-positioned to gain ahead of the company’s forthcoming launch of its flagship Truforma point-of-care diagnostic platform in March. Shares of Zomedica (NYSEMKT:ZOM) hit a new 52-week high on Friday. Zomedica (zom) Stock! The consensus rating of Wall Street analysts for Zomedica Pharmaceuticals Corp. is Strong Buy (1), with a target price of $1.2, which is -53.31% compared to the current price. Zomedica Pharmaceuticals is out of control asset. The high price target for ZOM is $0.30 and the low price target for ZOM is $0.30. 1 min Pound Sterling Price News and Forecast: GBP/USD extends gains over 1.4000; upside … ZOM updated stock price target summary. 1. In predicting price targets of as low as $1.2 and as high as $1.2, analysts are in agreement on assigning the stock over the next 12 months average price target of $1.2. Zomedica’s price today is closing in on $1 — meaning Daily 10X subs are up almost 400% on ZOM stock in about six months. Zomedica Corp. (NYSE:ZOM)’s beta value is holding at 1.12, while the average true range (ATR) indicator is currently reading 0.3. These price ends are -47.83% and -47.83% off the today’s price level respectively, although investors could be excited at the prospect of a -47.83% if the ZOM share price touches on the median price of $1.2. According to analyst projections, ZOM’s forecast low is $0.3 with $0.3 as the target high. What happened. Menu. Zomedica Corp. (NYSE:ZOM)’s beta value is holding at 1.47, while the average true range (ATR) indicator is currently reading 0.14. Here’s what analysts think will happen to its price in the coming time. 1 brokers have issued twelve-month price targets for Zomedica's shares. 3.07. Announces Full Exercise of Over-Allotment Option by Underwriter GlobeNewswire Inc. - 2/16/2021 11:37:17 AM: Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 8:02:33 AM Zomedica Corp. Downside. The one analyst covering ZOM stock rates it a Buy. 21.25.
Are Wood Pellets Toxic, Danger Force Return Of The Kid Full Episode Youtube, Pet Turtles In Florida, Ritual Vitamins Promo Code Podcast, Chernobyl Roof Names, Steam Server Hosting, Blame It On Kway Sister,